Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. - Wikidata - thesis-toulmin - TriplyDB

Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

http://www.wikidata.org/entity/Q36041225

about

Cytotoxic granule secretion by lymphocytes and its link to immune homeostasis Interleukin-1 Family Cytokines in Liver Diseases Newly recognized Mendelian disorders with rheumatic manifestations Review of autoinflammatory diseases, with a special focus on periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome Early-onset autoimmune disease as a manifestation of primary immunodeficiency Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production Inflammation-a Critical Appreciation of the Role of Myeloid Cells New monogenic autoinflammatory diseases--a clinical overview Toward an Inclusive, Congruent, and Precise Definition of Autoinflammatory Diseases Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.Genetically defined autoinflammatory diseases.A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner.Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.Genetic and Epigenetic Determinants in Autoinflammatory Diseases.Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.The burgeoning field of innate immune-mediated disease and autoinflammation.Dermatologic Manifestations of Monogenic Autoinflammatory Diseases.Lessons from characterization and treatment of the autoinflammatory syndromes.Integrated classification of inflammatory myopathies.The role of neuroimmune signaling in alcoholism.The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases.Paediatric systemic lupus erythematosus: insights from translational research.Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases.Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.Primary immunodeficiencies suggest redundancy within the human immune system.Airway and serum biochemical correlates of refractory neutrophilic asthma.Chronic inflammation triggered by the NLRP3 inflammasome in myeloid cells promotes growth plate dysplasia by mesenchymal cells.Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis.Autophagy dysfunction in autoinflammatory diseases.Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.Activation of the Innate Immune Receptors: Guardians of the Micro Galaxy : Activation and Functions of the Innate Immune Receptors.The NLRC4 Inflammasome.Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.

P2860

Q26776499-6FB97F67-EF90-48CD-AC19-F6F507C118C6 Q26778553-B783E2D2-7E3A-4CB3-8138-EC5BD5E239E3 Q26996730-7DBAFBB6-B651-4EF2-B027-659C05C0612A Q28066401-8435EED7-E999-4BCD-9EE3-C9A39E77A51B Q28082860-DF282BAB-FABD-40E6-864D-6D28B2C78548 Q28114794-A1F2D538-CB0E-42BF-80BD-D0CAB52EEEBB Q28595434-F2B4D55D-D4B3-45FC-8BDB-DABFA8DF93C5 Q36016335-92EEBBCB-1FF7-4AD1-9C95-13B117CBF057 Q36369784-06535FFD-71ED-4938-98C1-9F01B3D1B362 Q37328410-DDE43DAA-7729-4D2B-91FB-60BE4FE8F3C6 Q37351626-BC6B4C7E-1C65-4BFA-8AC4-73403090E3B4 Q38574807-BFFD0DA8-2743-4C03-BF08-476F998AEA7C Q38653628-CB9A7FE7-D6A5-4E4D-9B4D-907906CDE3EC Q38708244-6F9CA3BB-60C2-40C2-AF3A-590FD0E7E552 Q38720044-474D68B7-0A55-472B-9A6E-A87ED4BF3D66 Q38773387-455B231F-B1FE-4D22-8992-0A96CC5FC259 Q38843398-BEBC53DC-B7C1-4537-85F3-071159026623 Q38851405-36315BF0-735E-41BB-8A7B-6895832E8A83 Q38925521-2B2E9E3B-CDF1-4546-B82A-4E4C9C747AD4 Q38966512-C5AB4C00-8BAA-4389-A538-D0412A4083B7 Q38967233-F9D9964A-B9B5-4415-9B02-01F9D5F943F2 Q39021328-8E1FAF64-8F91-4024-B3C2-E3639DE5D770 Q39025839-799FDD43-0F60-4EB2-98B8-1033A01FD653 Q39027323-5A8C47FD-4CA1-4485-AC11-3159992EC667 Q39118808-4CF319E8-1BDB-4DD6-B3F4-0F9885094370 Q39132605-82482865-0127-46A9-A789-1DC4E658F5AC Q39218852-B6EF4725-36C3-423E-B032-E7461E2749D7 Q39413866-00CBD8D0-D79B-403B-ADB6-9A4994863254 Q40044596-E9C52EB3-62D0-4FA6-87CF-2AE7CD01ABE2 Q40103750-2F51407B-1274-4575-AEBF-0A73A32A26D5 Q40344650-CB564291-DE80-4615-A75B-6667B11DDF68 Q40961428-7C33EA7E-4437-46E5-8C43-32184A079517 Q41115687-EC98E585-FA76-4ECC-B1E1-2B0A3284712E Q47123805-50B364F7-A14F-4DED-BE62-69653650F272 Q47400159-A1E84FEC-BDB9-4954-84E9-F7339680AED7 Q47434993-9D521341-8298-4B7F-AF7C-B6C3AA6E055A Q47602482-AFE0BC64-2971-437E-9E11-F1CA36A10FDB Q47943969-00FC6F1D-B641-49FC-BB86-A0164CF23B56 Q48105566-D6718E41-4F87-41B3-87D3-C780B17859F7 Q48258109-BA8A749C-05BA-4639-9A53-6E154DFFFBA1

P2860

Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

http://www.wikidata.org/entity/Q36041225

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Molecular mechanisms in geneti ...... of amplified danger signaling.

@ast

Molecular mechanisms in geneti ...... of amplified danger signaling.

@en

type

label

Molecular mechanisms in geneti ...... of amplified danger signaling.

@ast

Molecular mechanisms in geneti ...... of amplified danger signaling.

@en

prefLabel

Molecular mechanisms in geneti ...... of amplified danger signaling.

@ast

Molecular mechanisms in geneti ...... of amplified danger signaling.

@en

P1433

Q36041225-7A15CBAF-4EDD-4F91-AA70-92627DB9961C

P1476

Q36041225-EC151448-FED1-4759-993C-FA5A01690DF6

P2093

Q36041225-6417A751-5372-4D05-BE50-90DB08498251

Q36041225-68EDD7F3-F23A-41BA-A9A3-76D04DED2503

Q36041225-71E803C6-AF42-4C15-B1C8-ACC428BA8301

Q36041225-ADC9B0F9-DE6F-4784-8763-99C370C66679

P2860

Q36041225-00498906-D263-47B7-85C7-E41BD1BC680C

Q36041225-007BF7E2-5648-4577-8178-66F603998573

Q36041225-015EBA18-53E0-4693-9CD5-0CBFD9CAE618

Q36041225-03B20B65-5D1E-480E-9757-7DAE152F5677

Q36041225-05791006-CFDE-4632-BCE4-D1207DBCC2C9

Q36041225-064A6305-4DA1-4748-AD15-895A22591A83

Q36041225-07A60135-DC1A-48C6-B217-2968D06CF813

Q36041225-07BA0BB4-1D36-46FA-A589-A18BD3DBC932

Q36041225-07C511DC-350B-422A-8750-472177C1A0FB

Q36041225-09068C98-2DDF-4F0A-9726-DC34DB6910C4

P304

Q36041225-4C980BE4-D8E4-468B-B94F-4D2256ABD28A

P31

Q36041225-019600B2-1380-4083-9CB0-FD92D8A9365A

P356

Q36041225-FBCCA167-EC9F-4F7C-A95F-3797F6D58E2F

P478

Q36041225-5124B805-1A6F-4F45-899E-6FAF31BE6B48

P577

Q36041225-A9F1783D-835C-41D6-8656-B890575505F8

P5875

Q36041225-8CC3C189-09DE-4A9F-BC44-74402C9EC32A

P698

Q36041225-14935193-CD42-4BFF-ADD5-C740EABE53BF

P932

Q36041225-843D7438-695C-4A94-BEC7-D36007942BD2

P356

ANNUREV-IMMUNOL-032414-112227

P1433

Annual Review of Immunology

P1476

Molecular mechanisms in geneti ...... of amplified danger signaling.

@en

P2093

Adriana Almeida de Jesus

http://www.w3.org/2001/XMLSchema#string

Raphaela Goldbach-Mansky

http://www.w3.org/2001/XMLSchema#string

Scott W Canna

http://www.w3.org/2001/XMLSchema#string

Yin Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency

Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems

AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking

PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency

P304

823-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1146/ANNUREV-IMMUNOL-032414-112227

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272749200

http://www.w3.org/2001/XMLSchema#string

P698

25706096

http://www.w3.org/2001/XMLSchema#string

P932

4563985

http://www.w3.org/2001/XMLSchema#string